Global Aortic Stenosis Market Insights, Forecast to 2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Aortic Stenosis Market Insights, Forecast to 2034
Aortic stenosis is a valvular heart disease with varying severity. Narrowed valve openings of the large blood vessel aorta reduce blow flow making the heart pump excessively. Poor prognosis with a fatal mortality rate is observed in severe cases. In-time diagnosis and treatment are of significant importance.
Market Analysis and InsightsGlobal Aortic Stenosis Market
Global Aortic Stenosis market is expected to reach to US$ 5992 million in 2023, with a positive growth of %, compared with US$ 5398 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Aortic Stenosis industry is evaluated to reach US$ 10620 million in 2033. The CAGR will be 10.0% during 2023 to 2033.
Globally, Aortic Stenosis key companies include Abbott Laboratories, AstraZeneca Plc., Boston Scientific Corporation, Coroneo, CryoLife, Inc., Edwards Lifesciences Corporation, JenaValve Technology, Inc., LifeNet Health and LivaNova PLC, etc. Abbott Laboratories, AstraZeneca Plc., Boston Scientific Corporation are top 3 players and held % share in total in 2022.
When considering the consumption regions, % revenue of Aortic Stenosis were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033 and the share will be % in 2033. Moreover, China, plays a key role in the whole Aortic Stenosis market and estimated to attract more attentions from industry insiders and investors.
Aortic Stenosis can be divided into Transcatheter Aortic Valve Implantation (TAVI) and Surgical Aortic Valve Replacement (SAVR), etc. Transcatheter Aortic Valve Implantation (TAVI) is the mainstream product in the market, accounting for % revenue share globally in 2022 and the proportion will be % in 2033.
Aortic Stenosis is widely used in various fields, such as Congenital Aortic Stenosis and Acquired Aortic Stenosis, etc. Congenital Aortic Stenosis provides greatest supports to the Aortic Stenosis industry development. In 2022, global % revenue of Aortic Stenosis went into Congenital Aortic Stenosis filed and the proportion will reach to % in 2033.
Report Covers
This report presents an overview of global Aortic Stenosis market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Aortic Stenosis market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
Abbott Laboratories
AstraZeneca Plc.
Boston Scientific Corporation
Coroneo
CryoLife, Inc.
Edwards Lifesciences Corporation
JenaValve Technology, Inc.
LifeNet Health
LivaNova PLC
Medtronic Plc
Meril Life Sciences Pvt. Ltd.
Thubrikar Aortic Valve
Segment by Type
Transcatheter Aortic Valve Implantation (TAVI)
Surgical Aortic Valve Replacement (SAVR)
Congenital Aortic Stenosis
Acquired Aortic Stenosis
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Aortic Stenosis introduction, etc. Aortic Stenosis Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Aortic Stenosis
Chapter 13Methodology and Data Sources adopted by MRAResearch
Market Analysis and InsightsGlobal Aortic Stenosis Market
Global Aortic Stenosis market is expected to reach to US$ 5992 million in 2023, with a positive growth of %, compared with US$ 5398 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Aortic Stenosis industry is evaluated to reach US$ 10620 million in 2033. The CAGR will be 10.0% during 2023 to 2033.
Globally, Aortic Stenosis key companies include Abbott Laboratories, AstraZeneca Plc., Boston Scientific Corporation, Coroneo, CryoLife, Inc., Edwards Lifesciences Corporation, JenaValve Technology, Inc., LifeNet Health and LivaNova PLC, etc. Abbott Laboratories, AstraZeneca Plc., Boston Scientific Corporation are top 3 players and held % share in total in 2022.
When considering the consumption regions, % revenue of Aortic Stenosis were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033 and the share will be % in 2033. Moreover, China, plays a key role in the whole Aortic Stenosis market and estimated to attract more attentions from industry insiders and investors.
Aortic Stenosis can be divided into Transcatheter Aortic Valve Implantation (TAVI) and Surgical Aortic Valve Replacement (SAVR), etc. Transcatheter Aortic Valve Implantation (TAVI) is the mainstream product in the market, accounting for % revenue share globally in 2022 and the proportion will be % in 2033.
Aortic Stenosis is widely used in various fields, such as Congenital Aortic Stenosis and Acquired Aortic Stenosis, etc. Congenital Aortic Stenosis provides greatest supports to the Aortic Stenosis industry development. In 2022, global % revenue of Aortic Stenosis went into Congenital Aortic Stenosis filed and the proportion will reach to % in 2033.
Report Covers
This report presents an overview of global Aortic Stenosis market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Aortic Stenosis market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
By Company
Abbott Laboratories
AstraZeneca Plc.
Boston Scientific Corporation
Coroneo
CryoLife, Inc.
Edwards Lifesciences Corporation
JenaValve Technology, Inc.
LifeNet Health
LivaNova PLC
Medtronic Plc
Meril Life Sciences Pvt. Ltd.
Thubrikar Aortic Valve
Segment by Type
Transcatheter Aortic Valve Implantation (TAVI)
Surgical Aortic Valve Replacement (SAVR)
Segment by Application
Congenital Aortic Stenosis
Acquired Aortic Stenosis
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Aortic Stenosis introduction, etc. Aortic Stenosis Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Aortic Stenosis
Chapter 13Methodology and Data Sources adopted by MRAResearch